Search results for: HTA
Filter search results
Register Now for the OHE Conference on Drug Development in 2022
2 July 2012
…and elsewhere, the EMA, HTA agencies, life sciences companies, and academia. Confirmed to date are: Dr Richard Barker, Director of the Centre for Accelerating Medical Innovations, University of Oxford Professor…
OHE has an Opening for an Economist
4 September 2012
…sector; familiarity with HTA and medicines pricing and reimbursement in practice in one or more countries; strong quantitative skills Applications must be received by Monday, 24 September 2012. Interviews for…
Spotlight on OHE: Making Health Care Choices and Decisions
7 January 2013
OHE’s research and consulting captures a range of key issues that affect how health care systems are organised and how decisions are made within them. For example, how far to…
Andrés Pichon-Riviere
8 June 2025
…a PhD in Public Health (UBA). Andres is the Director of the Health Economics and Technology Assessment Department and the WHO/PAHO collaborating center in HTA at the Institute for Clinical…
OHE Occasional Paper Critiques the Claxton et al. £13,000 per QALY Estimate
24 February 2015
OHE has published an Occasional Paper highlighting the significant shortage of data that forced Claxton et al. to rely on a large number of strong assumptions to produce their results….
New OHE Publication: Model of Behaviour within Fuzzy Budget Constraints
23 December 2015
…regulator. A major preoccupation in health policy is the displacement of existing health care services when new technologies are mandated for reimbursement by HTA agencies. This opportunity cost is viewed…
5 Things You Should Do with EQ-5D Data
29 January 2016
…(a.k.a ‘utilities’) used in the calculation of QALYs (quality adjusted life years), EQ-5D has become the cornerstone of health technology appraisal (HTA), affecting important decisions about access to new medicines….
Opportunities for Utilising ‘Real World Data’ in South Korea
20 October 2017
…that can support this include electronic health records, claims databases, and clinical registries. Regulators and health technology assessment (HTA) bodies are increasingly requiring RWD to inform decision-making. In 2015, OHE…
Comparing Preference-based Outcome Measures for Overactive Bladder: EQ-5D-5L vs OAB-5D
31 January 2018
…on the OAB-5D, a condition-specific preference-based measure (PBM) of health. Cost-utility analysis forms an integral part of health technology assessment (HTA) in a growing number of countries. Societal preferences for…